Evaluation of pharmaceutical intervention in direct-acting antiviral agents for hepatitis C virus infected patients in an ambulatory setting: a retrospective analysis

Evaluation of pharmaceutical intervention in direct-acting antiviral agents for hepatitis C virus infected patients in an ambulatory setting: a retrospective analysis

Abstract Background Direct-acting antivirals (DAAs) are known to improve tolerability and have higher efficacy and shorter treatment durations compared with conventional interferon (IFN)-based treatments for hepatitis C virus (HCV) infection. Management of drug interactions and maintenance of patien...

Full description

Bibliographic Details
Main Authors: Haruna Yamamoto, Hiroaki Ikesue, Mai Ikemura, Rieko Miura, Kazumi Fujita, Hobyung Chung, Yoshiki Suginoshita, Tetsuro Inokuma, Tohru Hashida
Format: Article
Language:English
Published: BMC 2018-07-01
Series:Journal of Pharmaceutical Health Care and Sciences
Subjects:
Hepatitis C virus
Direct-acting antivirals
Pharmacist
Ambulatory care
Outpatients
Adherence
Online Access:http://link.springer.com/article/10.1186/s40780-018-0113-3

Internet

http://link.springer.com/article/10.1186/s40780-018-0113-3

Similar Items